News


Resident News

Cyclica Raises CAD$23 Million in a Series B Financing to Create the Biotech Pipeline of the Future

By JLABS

Read full story
Resident News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story
Resident News

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story
Resident News

Immunoscape studying immune response to Covid-19

By JLABS

Read full story
Resident News

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story
Resident News

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story
In the media

Uncovering global opportunities: a conversation with Jennifer Hamilton of Johnson & Johnson Innovation

By Highline Beta

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

By JLABS

Read full story
Other news

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement to develop superior antibody-drug conjugates

By JLABS

Read full story
Other news

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

By JLABS

Read full story
Other news

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

By JLABS

Read full story
Other news

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

By JLABS

Read full story
Other news

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm for Drug Development

By JLABS

Read full story
Other news

Avicanna Completes 2nd Equity Financing & Welcomes New Strategic Shareholder

By JLABS

Read full story